ERBB2 and glioblastoma: The authors found that in 41% of native GBM samples and most of the GBM cell lines investigated, ErbB2 protein expression was elevated, thereby inducing endogenous antitumor immunity and having long-term protection against rechallenge of distant tumors [36].